Ocular Therapeutix (OCUL) Presents At Cowen and Company 39th Annual Health Care Conference - Slideshow

( N A S D AQ: O C U L ) TRANSFORMING DRUG DELIVERY LEVERAGING A NOVEL TECHNOLOGY PLATFORM MICHAEL GOLDSTEIN, M.D., M.B.A. CHIEF MEDICAL OFFICER MARCH 2019 FORWARD LOOKING STATEMENTS Any statements in this presentation about future expectations, plans and prospects for the Company, including the commercialization of DEXTENZA®, ReSure Sealant, or any of the Company's product candidates, development and regulatory status of the Company's product candidates, such as the Company's anticipated commercial launch o ...